Two Sigma Investments’s Quoin Pharmaceuticals QNRX Stock Holding History

Two Sigma Investments’s Portfolio QNRX Stock Details QNRX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q3	–	Sell	-312	Closed	-$6.33K	–	3297
2024 Q2	$6.33K	Buy	+312	New	+$7.93K	﹤0.01%	2972

Other funds holding QNRX

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

TSS

Two Sigma Securities New York $861M AUM 21.33% 1-Year Est. Return

Virtu Financial New York $2.41B AUM 48.35% 1-Year Est. Return

RJFSA

Raymond James Financial Services Advisors St. Petersburg, Florida $75.1B AUM 31.89% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

RhumbLine Advisers Boston, Massachusetts $117B AUM 29.66% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

HNB

Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Two Sigma Investments's QNRX Position: Q3 2024 in Review

Two Sigma Investments sold out of Quoin Pharmaceuticals (QNRX) in Q3 2024, closing a stake of 312 shares — an estimated $6.33K sold.

Two Sigma Investments first reported a position in QNRX in Q2 2024 and held it in 1 quarter. The position peaked at $6.33K in Q2 2024. 7 funds tracked by Wall St. Rank hold QNRX as of Q3 2024.

Two Sigma Investments reported no remaining Quoin Pharmaceuticals position as of Q3 2024 after selling out during the quarter.
Two Sigma Investments sold 312 Quoin Pharmaceuticals shares in Q3 2024, an estimated $6.33K.
Two Sigma Investments first reported a position in Quoin Pharmaceuticals in Q2 2024 and held it in 1 quarter.
Two Sigma Investments's Quoin Pharmaceuticals position peaked at $6.33K in Q2 2024.
7 funds tracked by Wall St. Rank held Quoin Pharmaceuticals as of Q3 2024.

Based on Two Sigma Investments's 13F filing for Q3 2024, filed 14 Nov 2024.